AU2003246187A1 - MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR - Google Patents
MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTORInfo
- Publication number
- AU2003246187A1 AU2003246187A1 AU2003246187A AU2003246187A AU2003246187A1 AU 2003246187 A1 AU2003246187 A1 AU 2003246187A1 AU 2003246187 A AU2003246187 A AU 2003246187A AU 2003246187 A AU2003246187 A AU 2003246187A AU 2003246187 A1 AU2003246187 A1 AU 2003246187A1
- Authority
- AU
- Australia
- Prior art keywords
- actiavtor
- ppar
- gamma
- composition containing
- medicinal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002184462 | 2002-06-25 | ||
JP2002-184462 | 2002-06-25 | ||
PCT/JP2003/008053 WO2004000356A1 (ja) | 2002-06-25 | 2003-06-25 | 利尿剤及びペルオキシソーム増殖因子活性化受容体(PPAR)γ活性化剤を含有する医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003246187A1 true AU2003246187A1 (en) | 2004-01-06 |
Family
ID=29996706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003246187A Abandoned AU2003246187A1 (en) | 2002-06-25 | 2003-06-25 | MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003246187A1 (ja) |
TW (1) | TW200403055A (ja) |
WO (1) | WO2004000356A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ570381A (en) * | 2006-02-09 | 2011-02-25 | Daiichi Sankyo Co Ltd | Anti-cancer pharmaceutical composition |
TW201336497A (zh) * | 2007-02-08 | 2013-09-16 | Daiichi Sankyo Co Ltd | 噻唑啶二酮化合物之結晶型及其製法 |
JPWO2010013769A1 (ja) | 2008-07-31 | 2012-01-12 | 第一三共株式会社 | チアゾリジンジオン化合物の結晶及びその製造方法 |
US20110124692A1 (en) | 2008-07-31 | 2011-05-26 | Daiichi Sankyo Company, Limited | Crystalline forms of thiazolidinedione compound and its manufacturing method |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ293016B6 (cs) * | 1995-06-01 | 2004-01-14 | Sankyo Company Limited | Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem |
JP4549443B2 (ja) * | 1996-12-11 | 2010-09-22 | ダナ−ファーバー キャンサー インスティテュート インク. | 腫瘍細胞の成長を阻害するための方法および製薬学的組成物 |
AU5811298A (en) * | 1996-12-31 | 1998-07-31 | Salk Institute For Biological Studies, The | Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor |
TW475931B (en) * | 1997-10-08 | 2002-02-11 | Sankyo Co | A substituted condensed heterocyclic compound |
WO2000030628A2 (en) * | 1998-11-20 | 2000-06-02 | Genentech, Inc. | Method of inhibiting angiogenesis |
TR200103183T2 (tr) * | 1999-04-07 | 2002-05-21 | Sankyo Company Limited | Amin türevi bileşimler |
AU2001278738A1 (en) * | 2000-08-16 | 2002-02-25 | Sankyo Company Limited | Medicinal compositions for preventing and treating cancer |
-
2003
- 2003-06-25 TW TW092117200A patent/TW200403055A/zh unknown
- 2003-06-25 AU AU2003246187A patent/AU2003246187A1/en not_active Abandoned
- 2003-06-25 WO PCT/JP2003/008053 patent/WO2004000356A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004000356A1 (ja) | 2003-12-31 |
TW200403055A (en) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003291024A1 (en) | Rhodanine derivatives and pharmaceutical compositions containing them | |
HUP0204557A3 (en) | Benzazole derivatives, their use as jnk modulators, their preparation and pharmaceutical compositions containing them | |
AU2003289440A1 (en) | Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof | |
AU2002335231A1 (en) | Activator for peroxisome proliferator-activated receptor delta | |
IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
AU2003262262A1 (en) | Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof | |
HUP0200831A2 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
AU2003278393A1 (en) | New use for pharmaceutical composition | |
AU2002224139A1 (en) | Ppar (peroxisome proliferator activated receptor) activators | |
AU775774C (en) | Peroxisome proliferator-activated receptor agonist | |
HUP0402486A3 (en) | Nitrogen containing heterocyclic compounds as peroxisome proliferator activated receptor agonists, their use and pharmaceutical compositions cointaining them | |
AU2003225027A1 (en) | Combination therapy using a ppar alpha/gamma agonist | |
AU2003270389A1 (en) | Composition containing feverfew extract and use thereof | |
AU2003281687A1 (en) | Photopolymerizable composition and use thereof | |
AU2003278814A1 (en) | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof | |
AU2001229378A1 (en) | Antisense modulation of peroxisome proliferator-activated receptor gamma expression | |
AU2003246187A1 (en) | MEDICINAL COMPOSITION CONTAINING DIURETIC AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma ACTIAVTOR | |
AU1732401A (en) | Medicinal compositions for oral use | |
AU2003301802A1 (en) | New pharmaceutical compositions containing ambroxol and isopropamide iodide | |
AU2003303376A1 (en) | Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators | |
AU2003206014A1 (en) | Neuropeptide receptor and uses thereof | |
AU2003269654A1 (en) | Nuclear receptor transcriptional corepressor and uses thereof | |
AU2003213432A1 (en) | Photosensitive resin composition and use thereof | |
AU2003280799A1 (en) | Medicinal composition | |
AU2003261927A1 (en) | Peroxisome proliferator-activated receptor controllers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |